• Home
  • Social Media Team
  • test live stream

Menu
  • Home
  • Social Media Team
    • Jack Aiello
    • Yelak Biru
    • Cynthia Chmielewski
    • John DeFlice
    • Linda Huguelet
    • Teresa Miceli
    • Jim Omel
    • Valarie Traynham
    • Michael Tuohy
    • Robin Tuohy
    • Tiffany Williams
    • Yvonne Yaksic
    • Close
  • ASH 2018 Abstracts
  • Videos from ASH/ASCO
  • IMF Website

Recent Blog Posts from ASH 2018

  • Yvonne Yaksik: A Support Group Leader’s Perspective

    Yvonne Yaksic | December 18, 2018

     Yvonne Yaksik talks about her experiences at ASH 2018 and the key takeaways from the sessions she attended.

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    All Hail #MyelomaWarriors

    Yelak Biru | December 18, 2018

    The International Myeloma Foundation kicked off the 2018 March Myeloma Action month with the focus on the #MyelomaWarrior. On the plane I was on from DFW to SAN to attend the 60th American Society of Hematology Annual Meeting & Exposition held in San Diego from December 1 – 4, 2018, there was a Warrior, in […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    Valarie Traynham: ASH Experience for a First Time Attendee

    Valarie Traynham | December 18, 2018

    Valarie Traynham provides a first time attendee’s perspective on ASH.

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    Teresa Miceli: A Support Group Leader’s Perspective

    Teresa Miceli | December 17, 2018

     Teresa Miceli talks about her experiences at ASH 2018 and the key takeaways from the sessions she attended.

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    A Grateful ❤️

    Yvonne Yaksic | December 12, 2018

    As I reflect on my first attendance at ASH, three things stand out in my mind: After seeing the presentations of the hard-working, brilliant and dedicated doctors and researchers, I know in my heart there will someday be a cure for Multiple Myeloma. I also include the brave patients, who help all Myeloma patients, by […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    #ASH18 – Coming to a Close

    Teresa Miceli | December 11, 2018

    The American Society of Hematology (#ASH18) annual meeting is has come to an end. Monday has been traditionally known as “Myeloma Madness Monday.” This year was no different. Oral sessions included topics on the combination therapies, #CAR-T and #BiTE (Bispecific T-cell Engager) therapy. Other potential new agents in #myeloma, like venetoclax, selinexor and isatuximab, were […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    Twitter at #ASH18

    Cynthia Chmielewski | December 11, 2018

    Twitter is a greatly misunderstood social media tool. When I suggest to someone to join Twitter I usually get the response, ”I don’t do Twitter.” Twitter first appeared on the social media circuits on March 21, 2006. Much of what I know about myeloma I have learned on Twitter. The use of Twitter at #ASH18 helped […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    BiTEs to the Fight

    Cynthia Chmielewski | December 10, 2018

    The treatment of myeloma is rapidly changing. When I first attended the American Society of Hematology’s (ASH) Annual Meeting in 2012 Immunotherapy was still in its infancy. Although immunotherapy options were being evaluated in clinical trials, they were not available to myeloma patients in clinical practice. November, 2015 was dubbed the November to remember in […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    ASH 2018: Overwhelming But Enriching

    Valarie Traynham | December 10, 2018

    ASH 2018 has come and gone, but the numerous abstracts and information presented will be built upon for many years to come. As a first time attendee to the ASH conference, I found it to be a very enriching experience. The abundance of information was overwhelming and seemed to be too much for me to […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)
  •

    Recollections of the 60th Annual ASH Meeting and Expo

    Jim Omel | December 7, 2018

    ASH is over but its memories are fresh. My strongest impression of the meeting is that multiple myeloma treatment advances continue to be significant at this huge yearly event. Dr. Durie explained there were an amazing 939 abstracts relating to myeloma at ASH this year. At the IMWG (International Myeloma Working Group) meeting, he said […]

    Share this:

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on Pinterest (Opens in new window)
    • Click to print (Opens in new window)

THIS WEBSITE IS HOSTED BY THE INTERNATIONAL MYELOMA FOUNDATION ("IMF") FOR MULTIPLE MYELOMA SUPPORT GROUPS. THE CONTENT APPEARING ON THIS WEBPAGE IS NOT CONTROLLED OR PROVIDED BY IMF, AND IMF NEITHER WARRANTS NOR GUARANTEES THE ACCURACY OF SUCH CONTENT. THE FOREGOING NOTWITHSTANDING, THE CONTENT IS NOT A SUBSTITUTE FOR ADVICE AND SERVICE PROVIDED BY QUALIFIED AND LICENSED MEDICAL PROFESSIONALS, AND SHOULD NOT BE RELIED ON WITH RESPECT TO ANY HEALTH MATTERS. ANY HEALTH-RELATED INFORMATION FOUND HEREIN IS ONLY MADE AVAILABLE AS PART OF A GENERAL EDUCATIONAL SERVICE.

 

with support from: